Short term outcomes of helical tomotherapy during concurrent chemoradiotherapy for advanced cervical cancer

被引:8
作者
Mabuchi, Yasushi [1 ]
Takiguchi, Yoshihiro [1 ]
Yahata, Tamaki [1 ]
Mizoguchi, Mika [1 ]
Sasaki, Noriyuki [1 ]
Ota, Nami [1 ]
Minami, Sawako [1 ]
Ino, Kazuhiko [1 ]
机构
[1] Wakayama Med Univ, Sch Med, Dept Obstet & Gynecol, 811-1 Kimiidera, Wakayama, Wakayama 6410012, Japan
关键词
helical tomotherapy; concurrent chemoradiotherapy; cervical cancer; radiation therapy; outcome; PELVIC RADIATION-THERAPY; EARLY CLINICAL-OUTCOMES; TOXICITY; CHEMOTHERAPY; CARCINOMA; TRIAL;
D O I
10.3892/mco.2019.1806
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of the present study was to clarify the feasibility and efficacy of helical tomotherapy during concurrent chemoradiotherapy for treating cervical cancer. The medical records of 13 patients who underwent oncurrent chemoradiotherapy using helical tomotherapy for cervical cancer at Wakayama Medical University Hospital between 2013 and 2015 were retrospectively reviewed. A total of 15 patients who underwent oncurrent chemoradiotherapy using conventional radiotherapy (CRT) between 2008 and 2013 at our institution were also examined for comparison. The median age of patients treated with helical tomotherapy was 60 (range, 35-71), and the median age of patients treated with CRT was 57 (range, 43-77). The median follow-up period was 27 months (range, 3-46) in the tomotherapy group and 35 months (range, 7-88) in the CRT group. The frequency of G3/4 thrombocytopenia in the tomotherapy group was significantly higher than that in the CRT group (P=0.049). However, the platelet count spontaneously recovered without transfusion. There were no significant differences between the groups in terms of frequency of G3/4 neutropenia, diarrhea or late intestine injury. The rate of complete response in the tomotherapy group and the CRT group was 84.6 and 73.3%, respectively, and there was no significant difference in the response rate between the groups. There were no significant differences in the progression-free survival or progression-free rate in the irradiation field between the groups. Adverse events from concurrent chemoradiotherapy using helical tomotherapy were acceptable and clinically controllable. The present results suggest that helical tomotherapy is efficient during concurrent chemoradiotherapy for treatment of advanced cervical cancer.
引用
收藏
页码:382 / 386
页数:5
相关论文
共 9 条
  • [1] SPLIT-FIELD HELICAL TOMOTHERAPY WITH OR WITHOUT CHEMOTHERAPY FOR DEFINITIVE TREATMENT OF CERVICAL CANCER
    Chang, Albert J.
    Richardson, Susan
    Grigsby, Perry W.
    Schwarz, Julie K.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (01): : 263 - 269
  • [2] Early Clinical Outcomes and Toxicity of Intensity Modulated Versus Conventional Pelvic Radiation Therapy for Locally Advanced Cervix Carcinoma: A Prospective Randomized Study
    Gandhi, Ajeet Kumar
    Sharma, Daya Nand
    Rath, Goura Kisor
    Julka, Pramod Kumar
    Subramani, Vellaiyan
    Sharma, Seema
    Manigandan, Durai
    Laviraj, M. A.
    Kumar, Sunesh
    Thulkar, Sanjay
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (03): : 542 - 548
  • [3] Toxicity and early clinical outcomes in cervical cancer following extended field helical tomotherapy to para-aortic lymph nodes
    Jouglar, E.
    Thomas, L.
    de la Rochefordiere, A.
    Noel, G.
    Le Blanc-Onfroy, M.
    Delpon, G.
    Campion, L.
    Mahe, M. -A.
    [J]. CANCER RADIOTHERAPIE, 2016, 20 (08): : 794 - 800
  • [4] Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma
    Keys, HM
    Bundy, BN
    Stehman, FB
    Muderspach, LI
    Chafe, WE
    Suggs, CL
    Walker, JL
    Gersell, D
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (15) : 1154 - 1161
  • [5] A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer
    Kirwan, JM
    Symonds, P
    Greene, JA
    Tierney, J
    Collingwood, M
    Williams, CJ
    [J]. RADIOTHERAPY AND ONCOLOGY, 2003, 68 (03) : 217 - 226
  • [6] HELICAL TOMOTHERAPY VERSUS CONVENTIONAL INTENSITY-MODULATED RADIATION THERAPY FOR PRIMARY CHEMORADIATION IN CERVICAL CANCER PATIENTS: AN INTRAINDIVIDUAL COMPARISON
    Marnitz, Simone
    Lukarski, Dusko
    Koehler, Christhardt
    Wlodarczyk, Waldemar
    Ebert, Andreas
    Budach, Volker
    Schneider, Achim
    Stromberger, Carmen
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : 424 - 430
  • [7] Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix
    Peters, WA
    Liu, PY
    Barrett, RJ
    Stock, RJ
    Monk, BJ
    Berek, JS
    Souhami, L
    Grigsby, P
    Gordon, W
    Alberts, DS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (08) : 1606 - 1613
  • [8] PROSPECTIVE PHASE I-II TRIAL OF HELICAL TOMOTHERAPY WITH OR WITHOUT CHEMOTHERAPY FOR POSTOPERATIVE CERVICAL CANCER PATIENTS
    Schwarz, Julie K.
    Wahab, Sasa
    Grigsby, Perry W.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (05): : 1258 - 1263
  • [9] A randomized trial of concurrent chemoradiotherapy versus radiotherapy in advanced carcinoma of the uterine cervix
    Tseng, CJ
    Chang, CT
    Lai, CH
    Soong, YK
    Hong, JH
    Tang, SG
    Hsueh, S
    [J]. GYNECOLOGIC ONCOLOGY, 1997, 66 (01) : 52 - 58